Barclays’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.2M Sell
1,745,751
-132,406
-7% -$4.37M 0.02% 707
2025
Q4
$67.4M Sell
1,878,157
-246,396
-12% -$7.52M 0.03% 642
2025
Q3
$51.2M Buy
2,124,553
+25,493
+1% +$533K 0.02% 755
2025
Q2
$30.9M Buy
2,099,060
+756,579
+56% +$8.81M 0.01% 907
2025
Q1
$12.8M Buy
1,342,481
+570,101
+74% +$5.99M 0.01% 1254
2024
Q4
$9.6M Sell
772,380
-1,358,522
-64% -$14M ﹤0.01% 1604
2024
Q3
$20.8M Sell
2,130,902
-2,559,245
-55% -$30M 0.01% 1050
2024
Q2
$75.6M Buy
4,690,147
+2,611,175
+126% +$47.1M 0.03% 485
2024
Q1
$44.5M Sell
2,078,972
-1,014,189
-33% -$19.1M 0.02% 662
2023
Q4
$47.2M Buy
3,093,161
+2,727,791
+747% +$48.4M 0.02% 697
2023
Q3
$8.43M Sell
365,370
-81,343
-18% -$1.85M 0.01% 1066
2023
Q2
$10.6M Buy
+446,713
New +$10.2M 0.01% 971

Other funds holding INDV